Intelligent Cardiovascular Disease Diagnosis and Monitoring System
Legal Citation
Summary of the Inventive Concept
A novel system integrating electrochemical impedance spectroscopy with AI, IoT, blockchain, and nanomaterials for accurate cardiovascular disease diagnosis, monitoring, and personalized health recommendations.
Background and Problem Solved
The original patent addressed the limitations of conventional plaque rupture detection methods, but it lacked the integration of advanced technologies to enhance its capabilities. The new inventive concept overcomes this limitation by combining electrochemical impedance spectroscopy with AI, IoT, blockchain, and nanomaterials to provide a comprehensive and accurate cardiovascular disease diagnosis and monitoring system.
Detailed Description of the Inventive Concept
The system comprises a tissue sensing device (as described in the original patent) that collects electrical impedance spectroscopy data, which is then transmitted to a cloud-based IoT platform for analysis using artificial intelligence algorithms. The system also incorporates a machine learning module trained on a dataset of plaque rupture events, a blockchain-based data storage system for securely storing and sharing patient data, and a nanomaterial-based contrast agent for enhancing ultrasound imaging. The system's components work synergistically to identify high-risk atherosclerotic lesions, detect metabolically active lesions, and provide personalized health recommendations.
Novelty and Inventive Step
The new inventive concept's novelty lies in the integration of electrochemical impedance spectroscopy with AI, IoT, blockchain, and nanomaterials, which enables accurate cardiovascular disease diagnosis, monitoring, and personalized health recommendations. The inventive step is the synergistic combination of these distinct technologies to create a more powerful system.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of sensors or imaging modalities, integrating with other healthcare systems or wearables, or applying the system to other disease diagnosis and monitoring applications.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of cardiovascular disease diagnosis and monitoring. The system's ability to provide accurate and personalized health recommendations can lead to improved patient outcomes, reduced healthcare costs, and increased market share for companies adopting this technology.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, medical diagnostics, specifically cardiovascular imaging and sensing technologies with expertise in electrochemical impedance spectroscopy, ultrasound imaging, and advanced data analysis techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with advanced degrees, proficient in medical sensor design, signal processing, machine learning, and interdisciplinary technology integration, familiar with emerging diagnostic technologies and computational healthcare solutions
Obviousness Rationale
A PHOSITA would recognize that the PTD represents a predictable combination of known medical diagnostic technologies, extending the source patent's tissue sensing device through standard engineering techniques of integrating machine learning, IoT platforms, and advanced data analysis methods. The core tissue sensing mechanism remains fundamentally unchanged, with added computational and data management layers that represent incremental technological improvements. The proposed variations demonstrate standard technological evolution by applying known computational techniques to an existing medical sensing framework.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,318 |
|---|---|
| Title | Electrochemical impedance spectroscopy |
| Assignee(s) | The Regents of the University of California |